Price Alert: Shares of RiceBran (RIBT) Trade 8.58% Lower at Midday June 23

Equities Staff  |

Shares of RiceBran Technologies (NASDAQ: RIBT) lost 8.58% Thursday.

As of 12:09:47 est, RiceBran is currently sitting at $0.74 and has fallen $0.068  so far today.

RiceBran has moved 11.69% over the last 30 days and has a YTD change of 127.22% based on the prior day’s close.

The company expects its next earnings on 2022-08-03.

For technical charts, analysis, and more on RiceBran visit the company profile.

About RiceBran Technologies

RiceBran Technologies is a global leader in the production and marketing of value-added products derived from rice bran as well as a producer of rice, rice co-product, and barley and oat products. The target markets for its products include food and animal nutrition manufacturers and retailers, as well as specialty food, functional food and nutritional supplement manufacturers and retailers. Its highly nutritious and clean label ingredient products derived from rice bran, one of the world's most underutilized food sources, are produced utilizing our proprietary stabilization technology.

To get more information on RiceBran Technologies and to follow the company's latest updates, you can visit the company's profile page here: RiceBran Technologies's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade



Market Movers

Sponsored Financial Content